Cervical Cancer Prevention in HIV-Infected Women Using the “See and Treat” Approach in Botswana
- 1 March 2012
- journal article
- review article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 59 (3) , 308-313
Abstract
Background: Cervical cancer is a major public health problem in resource-limited settings, particularly among HIV-infected women. Given the challenges of cytology-based approaches, the efficiency of new screening programs need to be assessed. Setting Community and hospital–based clinics in Gaborone, Botswana. Objective: To determine the feasibility and efficiency of the “see and treat” approach using visual inspection acetic acid (VIA) and enhanced digital imaging (EDI) for cervical cancer prevention in HIV-infected women. Methods: A 2-tier community-based cervical cancer prevention program was implemented. HIV-infected women were screened by nurses at the community using the VIA/EDI approach. Low-grade lesions were treated with cryotherapy on the same visit. Women with complex lesions were referred to our second tier specialized clinic for evaluation. Weekly quality control assessments were performed by a specialist in collaboration with the nurses on all pictures taken. Results: From March 2009 through January 2011, 2175 patients were screened for cervical cancer at our community-based clinic. Two hundred fifty-three patients (11.6%) were found to have low-grade lesions and received same-day cryotherapy. One thousand three hundred forty-seven (61.9%) women were considered to have a normal examination, and 575 (27.3%) were referred for further evaluation and treatment. Of the 1347 women initially considered to have normal exams, 267 (19.8%) were recalled based on weekly quality control assessments. Two hundred ten (78.6%) of the 267 recalled women, and 499 (86.8%) of the 575 referred women were seen at the referral clinic. Of these 709 women, 506 (71.4%) required additional treatment. Overall, 264 cervical intraepithelial neoplasia stage 2 or 3 were identified and treated, and 6 microinvasive cancers identified were referred for further management. Conclusions: Our “see and treat” cervical cancer prevention program using the VIA/EDI approach is a feasible, high-output and high-efficiency program, worthy of considering as an additional cervical cancer screening method in Botswana, especially for women with limited access to the current cytology-based screening services.Keywords
This publication has 32 references indexed in Scilit:
- Prevalence of human papillomavirus genotypes and associated cervical squamous intraepithelial lesions in HIV‐infected women in BotswanaJournal of Medical Virology, 2011
- Age-Specific Evaluation of Primary Human Papillomavirus Screening vs Conventional Cytology in a Randomized SettingJNCI: Journal of the National Cancer Institute, 2009
- Treatability by Cryotherapy in a Screen-and-Treat StrategyJournal of Lower Genital Tract Disease, 2009
- HPV Screening for Cervical Cancer in Rural IndiaNew England Journal of Medicine, 2009
- An Evaluation by Midwives and Gynecologists of Treatability of Cervical Lesions by Cryotherapy Among Human Papillomavirus-Positive WomenInternational Journal of Gynecological Cancer, 2009
- HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapyEuropean Journal Of Cancer Prevention, 2008
- Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing CountriesVaccine, 2008
- Modeling Cervical Cancer Prevention in Developed CountriesVaccine, 2008
- Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and IndiaInternational Journal of Cancer, 2008
- Training for cervical cancer prevention programs in low‐resource settings: Focus on visual inspection with acetic acid and cryotherapyInternational Journal of Gynecology & Obstetrics, 2005